Lazard Asset Management’s Convey Health Solutions Holdings, Inc. CNVY Stock Holding History

Lazard Asset Management’s Portfolio CNVY Stock Details CNVY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-306	Closed	-$2K	–	2640
2022 Q1	$2K	Hold	306	–	–	﹤0.01%	2266
2021 Q4	$2K	Buy	+306	New	+$2.25K	﹤0.01%	2238

Other funds holding CNVY

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Lazard Asset Management's CNVY Position: Q2 2022 in Review

Lazard Asset Management sold out of Convey Health Solutions Holdings, Inc. (CNVY) in Q2 2022, closing a stake of 306 shares — an estimated $2K sold.

Lazard Asset Management first reported a position in CNVY in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 60 funds tracked by Wall St. Rank hold CNVY as of Q2 2022.

Lazard Asset Management reported no remaining Convey Health Solutions Holdings, Inc. position as of Q2 2022 after selling out during the quarter.
Lazard Asset Management sold 306 Convey Health Solutions Holdings, Inc. shares in Q2 2022, an estimated $2K.
Lazard Asset Management first reported a position in Convey Health Solutions Holdings, Inc. in Q4 2021 and held it in 2 quarters.
Lazard Asset Management's Convey Health Solutions Holdings, Inc. position peaked at $2K in Q1 2022.
60 funds tracked by Wall St. Rank held Convey Health Solutions Holdings, Inc. as of Q2 2022.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.